Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of a Blended Therapy Approach: Face-to-face Physiotherapy Sessions Combined With an Interactive Tablet-based Exercise Program for People With Rare Diseases.

NCT03713151 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT03713151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03713151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of a Blended Therapy Approach: Face-to-face Physiotherapy Sessions Combined With an Interactive Tablet-based Exercise Program for People With Rare Diseases.
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Completed
Start date
February 27, 2019
Completion date
April 30, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exercise, feasibility, haemophilia, myositis, telemedicine